Evidence map›Paper›PMID 33591483›Full record

ArticleJournal of cell communication and signaling2021

Glucose-limiting conditions induce an invasive population of MDA-MB-231 breast cancer cells with increased connexin 43 expression and membrane localization.

Jennifer C Jones, Amanda M Miceli, Mary M Chaudhry, Chloe S Kaunitz, Mallika A Jai, Romel N Pancho, Alan Lazzar, Bradley S Taylor, Vishnupriya Bodempudi, Prarthana P Jain and 5 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of cell communication and signaling, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Tumor-Tissue Boundaries as Instructive Interfaces in Breast Cancer Cell Invasion.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  3. Article
  4. Review
  5. Review
  6. Connexins and Glucose Metabolism in Cancer.International journal of molecular sciences · 2022
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Jennifer C JonesDepartment of Biochemistry and Molecular Genetics, Midwestern University, 555 31st Street, Downers Grove, IL, 60515, USA.
Amanda M MiceliChicago College of Pharmacy, Midwestern University, 555 31st Street, Downers Grove, IL, 60515, USA.
Mary M ChaudhryBiomedical Sciences Program, Midwestern University, 555 31st Street, Downers Grove, IL, 60515, USA.
Chloe S KaunitzChicago College of Osteopathic Medicine, Midwestern University, 555 31st Street, Downers Grove, IL, 60515, USA.
Mallika A JaiBiomedical Sciences Program, Midwestern University, 555 31st Street, Downers Grove, IL, 60515, USA.
Romel N PanchoBiomedical Sciences Program, Midwestern University, 555 31st Street, Downers Grove, IL, 60515, USA.
Alan LazzarBiomedical Sciences Program, Midwestern University, 555 31st Street, Downers Grove, IL, 60515, USA.
Bradley S TaylorBiomedical Sciences Program, Midwestern University, 555 31st Street, Downers Grove, IL, 60515, USA.
Vishnupriya BodempudiBiomedical Sciences Program, Midwestern University, 555 31st Street, Downers Grove, IL, 60515, USA.
Prarthana P JainChicago College of Osteopathic Medicine, Midwestern University, 555 31st Street, Downers Grove, IL, 60515, USA.
Sheeri HanjraBiomedical Sciences Program, Midwestern University, 555 31st Street, Downers Grove, IL, 60515, USA.
Alexander E UrbanChicago College of Osteopathic Medicine, Midwestern University, 555 31st Street, Downers Grove, IL, 60515, USA.
Brian ZanottiDepartment of Microbiology and Immunology, Midwestern University, 555 31st Street, Downers Grove, IL, 60515, USA.
Ellen K KohlmeirCore Facilities, Midwestern University, 555 31st Street, Downers Grove, IL, 60515, USA.
Thomas M BodenstineDepartment of Biochemistry and Molecular Genetics, Midwestern University, 555 31st Street, Downers Grove, IL, 60515, USA. tboden@midwestern.edu.ORCID http://orcid.org/0000-0002-6837-9796
Midwestern University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gap junctional intercellular communication (GJIC) is a homeostatic process mediated by membrane channels composed of a protein family known as connexins. Alterations to channel activity can modulate suppression or facilitation of cancer progression. These varying roles are influenced by the cancer cell genetic profile and the context-dependent mechanisms of a dynamic extracellular environment that encompasses fluctuations to nutrient availability. To better explore the effects of altered cellular metabolism on GJIC in breast cancer, we generated a derivative of the triple-negative breast cancer cell line MDA-MB-231 optimized for growth in low-glucose. Reduced availability of glucose is commonly encountered during tumor development and leads to metabolic reprogramming in cancer cells. MDA-MB-231 low-glucose adapted cells exhibited a larger size with improved cell-cell contact and upregulation of cadherin-11. Additionally, increased protein levels of connexin 43 and greater plasma membrane localization were observed with a corresponding improvement in GJIC activity compared to the parental cell line. Since GJIC has been shown to affect cellular invasion in multiple cancer cell types, we evaluated the invasive qualities of these cells using multiple three-dimensional Matrigel growth models. Results of these experiments demonstrated a significantly more invasive phenotype. Moreover, a decrease in invasion was noted when GJIC was inhibited. Our results indicate a potential response of triple-negative breast cancer cells to reduced glucose availability that results in changes to GJIC and invasiveness. Delineation of this relationship may help elucidate mechanisms by which altered cancer cell metabolism affects GJIC and how cancer cells respond to nutrient availability in this regard.

Indexed as

Breast cancerConnexinGap junction

Identifiers

PMID33591483
PMCPMC7991056
OpenAlexW3130407057

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.